Abstract Details

Title Assessing Prevalence and Efficacy of Medication Management Aids in Patients with Parkinson's Disease

Topic Movement Disorders

Presentation(s) P02 - (-)

Poster/Presentation
Number 086

Objective

Background BACKGROUND: Medication aids such as pill boxes and alarms can help improve medication adherence in geriatric populations. This has not been well-studied in PD.

Design/Methods DESIGN/METHODS: Patients with PD (disease duration ?1 year) with responsibility for managing their medications completed a medication adherence aid questionnaire and the 8-item Morisky Medication Adherence Scale (MMAS-8). Demographic data and medications were obtained from the medical record and clinical database.

Results RESULTS: Sixty-eight participants (mean age 68.3 years) had an average disease duration of 9.6 (SD 5.4) years and were on a total of 6.3 (SD 3.6) total different medications (range 1-17). 82% of patients reported use of one or more aids to manage their medications: 72% reported using pill boxes, 16% alarm reminders, and 13% phones with alarms; 47% received help from care partners. 5% used more than one aid. Patients who used aids of any kind were more likely to be highly adherent (MMAS-8 score 0-3, 84% vs. 75%) but this did not reach statistical significance (p=0.46). Analysis of adherence by type of aid showed similar findings across the aid types, with the exception of phones with alarms (n=9). Phone alarm use was associated with less high adherence (55% vs. 86%; p=0.03). Phone alarm users were younger (mean 61.9 vs. 69.3 years, p=0.01) and more likely to be white (100% vs. 90%, p=0.01) than non-users, with no other significant group differences.

Conclusions CONCLUSIONS: PD patients commonly use medication management aids and these are generally associated with high medication adherence, except for phone alarms. Future research is needed to confirm this finding and examine why use of phone alarms might be associated with lower adherence.

Authors/Disclosures
Katherine Holmes PRESENTER	No disclosure on file
	No disclosure on file
Giancarlo Comi, MD (University Vita-Salute)	Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Melissa Armstrong, MD, MSc, FAAN, FAAN (UF Department of Neurology)	The institution of Dr. Armstrong has received research support from National Institutes of Health. The institution of Dr. Armstrong has received research support from Florida Department of Health. The institution of Dr. Armstrong has received research support from Lewy Body Dementia Association. The institution of Dr. Armstrong has received research support from The Michael J. Fox Foundation. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Clinical Trials Consortium. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Disease Cooperative Study. Dr. Armstrong has received personal compensation in the range of $500-$4,999 for serving as a DSMB member with National Institutes of Health. Dr. Armstrong has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities.
Ann Gruber-Baldini	No disclosure on file
Karen Anderson	No disclosure on file
Stephen G. Reich, MD, FAAN (Univ of MD Hospital/Dept of Neuro)	Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Best Doctors. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UpToDate. Dr. Reich has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. Dr. Reich has received publishing royalties from a publication relating to health care. Dr. Reich has received publishing royalties from a publication relating to health care.
Gary S. Gronseth, MD, FAAN (University of Kansas)	Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain & Life. Dr. Gronseth has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as a Member/EBM consultant Guideline Development Subcommittee with AAN.
Gary S. Gronseth, MD, FAAN (University of Kansas)	Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain & Life. Dr. Gronseth has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as a Member/EBM consultant Guideline Development Subcommittee with AAN.
Paul S. Fishman, MD, PhD (Univ of Maryland Sch of Med)	No disclosure on file
William J. Weiner, MD	No disclosure on file
Lisa M. Shulman, MD, FAAN (University of Maryland School of Medicine)	The institution of Dr. Shulman has received research support from NIH. Dr. Shulman has received publishing royalties from a publication relating to health care. Dr. Shulman has received publishing royalties from a publication relating to health care.

��ɫ��

��ɫ��